Short Courses*

Tuesday, August 28, 6:30-9:00 pm

Dinner Short Course (SC1) Bioinformatics for Immuno-Oncology and Translational Research - Detailed Agenda

Instructor:
Yuriy Gusev, PhD, Associate Professor, Innovation Center for Biomedical Informatics (ICBI), Georgetown University

In this course, we cover major applications of Big Data, bioinformatics and systems biology for immuno-oncology research and development with major focus on translational research. We provide a User’s Guide to open access online resources and tools as well as overview of state-of-the-art methodologies and approaches to leveraging and integrating of a vast amount of information available through genome-wide molecular profiling, next-generation sequencing, etc. for the immuno-oncology applications. Several important immuno-oncology focus areas will be discussed in detail, such as computational immunophenotyping of tumor samples, HLA typing based on sequencing data, as well as computational methodologies for immunotherapy selection. Several case studies and brief live demos with hands-on exercises will be presented to illustrate the importance and added value of integrative bioinformatics analysis for immuno-oncology.

Tuesday, August 28, 6:30-9:00 pm

Dinner Short Course (SC2) Next-Generation Immunotherapies: Part 1 – Detailed Agenda

Please join us for a two-part dinner workshop series featuring presentations on the latest immunotherapy technologies from emerging companies. Learn about engineering the next-generation immunotherapies coming down the pipeline, including bi-specific and multi-specific antibody constructs, fully recombinant antibody prodrugs, innovative multivalent therapeutics, immunotherapeutic fusion proteins, antibody-drug conjugates, and other innovative approaches.

Instructors:
Mark Throsby, PhD, Executive Vice President & CSO, Merus NV
Wei Yan, PhD, CEO, Research, Sound Biologics
Volker Schellenberger, PhD, President & CEO, Amunix
W. Michael Kavanaugh, MD, CSO, Head, Research and Non-Clinical Development, Cytomx Therapeutics
Michael Comeau, Principal Scientist, Immunobiology, Aptevo Therapeutics

Wednesday, August 29, 6:00-9:00 pm

Dinner Short Course (SC3) Next-Generation Immunotherapies: Part 2 – Detailed Agenda

Please join us for a two-part dinner workshop series featuring presentations on the latest immunotherapy technologies from emerging companies. Learn about engineering the next-generation immunotherapies coming down the pipeline, including bi-specific and multi-specific antibody constructs, fully recombinant antibody prodrugs, innovative multivalent therapeutics, immunotherapeutic fusion proteins, antibody-drug conjugates, and other innovative approaches.

Instructors:
Phil Bland-Ward, PhD, CSO, Crescendo Biologics
Adam Foley-Comer, MD, CMO, KAHR Medical, Ltd.
Christian Gieffers, PhD, Vice President, Analytics/Protein Chemistry, Apogenix
Harun Rashid, PhD, Principal Scientist, Molecular Technology, Ambrx
Bruce Roberts, PhD, CSO, Vedanta Biosciences
Marnix Bosch, PhD, Chief Technical Officer, Northwest Biotherapeutics